Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × specific substance maruyama × Clear all
NCT03476018 2022-06-16

Trial to Optimally Show the Pharmacological Action of Z-100

Zeria Pharmaceutical

Phase 3 Completed
72 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02247232 2022-03-04

Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

Zeria Pharmaceutical

Phase 3 Completed
793 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡